Muestra la distribución de la producción WoS, Scopus y SciELO del autor.
Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.
| Firmas del autor | |
| Nombre | RODRIGUEZ, KATHERINE |
| Género | Mujer |
| Área Principal WOS | Medicine, Research & Experimental; Nanoscience & Nanotechnology; |
| Afiliación Principal | Universidad Nacional Andrés Bello |
Publicaciones en Chile
Citas Totales
Afiliaciones Chilenas
| WOS | #Pub |
|---|---|
| Medicine, Research & Experimental | 1 |
| Nanoscience & Nanotechnology | 1 |
| Scopus | #Pub |
|---|
| SciELO | #Pub |
|---|
| Autor | Género | # Pub |
|---|---|---|
| ARAYA, EYLEEN | - | 1 |
| RIVEROS, A. | Hombre | 1 |
| MORALES-ZAVALA, F. | Hombre | 1 |
| VELASCO-AGUIRRE, CAROLINA ANDREA | Mujer | 1 |
| ARRIAGADA, HECTOR | Hombre | 1 |
| ALDUNATE, REBECA | Mujer | 1 |
| KOGAN-BOCIAN, MARCELO JAVIER | Hombre | 1 |
| VASQUEZ-SALFATE, RODRIGO ALFONSO | Hombre | 1 |
| HASSAN-LOPEZ, NATALIA | Mujer | 1 |
| ALVAREZ-ROJAS, ALEJANDRA BEATRIZ | Mujer | 1 |
| MUNOZ, LUIS | Hombre | 1 |
| ROJAS-SILVA, XIMENA | Mujer | 1 |
| MINNITI, ALICIA N. | Mujer | 1 |
| Año | Firma | Institución (Incites asoc.) | H Index | Average Percentile | Impact Citation | Impact Relative World | Impact Journal Normalized Citation | Impact Category Normalized Citation | Percentage Cited | Percentage Top 1 | Percentage Top 10 | Percentage Journal Q1 | Percentage Journal Q2 | Percentage Journal Q3 | Percentage Journal Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2019 | Rodriguez, Katherine | Universidad Andres Bello | 1.0 | 11.4 | 9.0 | 1.0 | 1.2 | 1.6 | 100.0 | 0.0 | 0.0 | 100.0 | 0.0 | 0.0 | 0.0 |
| Título | Año | Citas | Tipo | Revista | Indexada |
|---|---|---|---|---|---|
| Peptide Multifunctionalized Gold Nanorods Decrease Toxicity Of Beta Amyloid Peptide In A Caenorhabditis Elegans Model Of Alzheimer's Disease | 2017 | 46 | artículo de investigación | Nanomedicine Nanotechnology Biology And Medicine | WoS Scopus |
| Palabra Clave | #Pub |
|---|---|
| aggregation | 1 |
| alzheimer's nanotherapy | 1 |
| amyloid-beta-peptide | 1 |
| brain delivery | 1 |
| c-elegans | 1 |
| cytotoxicity | 1 |
| drug-delivery | 1 |
| gold-nanoparticle | 1 |
| gold-nanorods | 1 |
| inclusion-body myositis | 1 |
| invertebrate models | 1 |
| mechanisms | 1 |
| nanoparticles | 1 |
| protein | 1 |
| synaptic defects | 1 |